Exclusive Industry News
A monthly read on where peptide regulation, testing, and the research-use-only market are heading — written plainly, for people who actually work in the space.
→
June 2026
State peptide rules split in two directions, the FDA reconsiders compounding, and why the research-use line is hardening.
July 2026
Our next monthly briefing — including takeaways from the FDA’s July compounding advisory meeting.
Coming soon